Tapewire

NYSE · USD

BLCO

Bausch & Lomb Corp

Export transactions ↓
Tapewire entity
3756
SEC CIK
0001860742
Parsed reports
240

Last 12 months

Inside the activity.

9 purchase rows · 3 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202640
Mar 202650
Apr 202600
May 202600
Jun 202600
Jul 202600
Aug 202603
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
February 27, 2026 Filed Mar 2, 2026 23:01 UTC
Bonnefoy LucPresident, Surgical
Tax withholdingCommon Shares, No Par Value 9,221 $18.30 $168,744.30
Disclosure

SEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 3

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 100,001

F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 23:01 UTC
Bonnefoy LucPresident, Surgical
Tax withholdingCommon Shares, No Par Value 4,311 $18.30 $78,891.30
Disclosure

SEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 2

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 109,222

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 22:46 UTC
Bailey A Robert DEVP & Chief Legal Officer
Tax withholdingCommon Shares, No Par Value 2,461 $18.30 $45,036.30
Disclosure

SEC source: 0001860742-26-000043 · form4.xml · nonDerivative · entry 2

Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 217,290

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 22:45 UTC
Eldessouky SamEVP and CFO
Tax withholdingCommon Shares, No Par Value 51,470 $18.30 $941,901.00
Disclosure

SEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 3

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 399,130

F2 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of performance-based restricted share units.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 22:45 UTC
Eldessouky SamEVP and CFO
Tax withholdingCommon Shares, No Par Value 15,507 $18.30 $283,778.10
Disclosure

SEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 2

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 450,600

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 27, 2026 Filed Mar 2, 2026 22:44 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
Tax withholdingCommon Shares, No Par Value 24,649 $18.30 $451,076.70
Disclosure

SEC source: 0001860742-26-000041 · form4.xml · nonDerivative · entry 2

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 951,875

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:24 UTC GrantCommon Shares, No Par Value 4,364 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000050 · form4.xml · nonDerivative · entry 2

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,814

F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

Read SEC document
February 27, 2026 Filed Mar 3, 2026 21:24 UTC PurchaseCommon Shares, No Par Value 4,364 $18.31 $79,883.02
Disclosure

SEC source: 0001860742-26-000050 · form4.xml · nonDerivative · entry 1

VON ESCHENBACH ANDREW C. · CIK 0001536529 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,450

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:00 UTC
Hashad YehiaEVP of R&D and CMO
Tax withholdingCommon Shares, No Par Value 2,169 $18.49 $40,104.81
Disclosure

SEC source: 0001860742-26-000045 · form4.xml · nonDerivative · entry 1

Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 196,737

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:04 UTC
Munsch FrederickSVP, Controller and CAO
Tax withholdingCommon Shares, No Par Value 2,042 $18.49 $37,756.58
Disclosure

SEC source: 0001860742-26-000048 · form4.xml · nonDerivative · entry 1

Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 106,442

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:03 UTC
Stewart Andrew J.President, GPIC
Tax withholdingCommon Shares, No Par Value 2,984 $18.49 $55,174.16
Disclosure

SEC source: 0001860742-26-000047 · form4.xml · nonDerivative · entry 1

Stewart Andrew J. · CIK 0001974516 · President, GPIC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 92,656

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 23:01 UTC
Bonnefoy LucPresident, Surgical
Tax withholdingCommon Shares, No Par Value 4,404 $18.49 $81,429.96
Disclosure

SEC source: 0001860742-26-000046 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 113,533

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:46 UTC
Bailey A Robert DEVP & Chief Legal Officer
Tax withholdingCommon Shares, No Par Value 3,395 $18.49 $62,773.55
Disclosure

SEC source: 0001860742-26-000043 · form4.xml · nonDerivative · entry 1

Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 219,751

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:45 UTC
Eldessouky SamEVP and CFO
Tax withholdingCommon Shares, No Par Value 7,062 $18.49 $130,576.38
Disclosure

SEC source: 0001860742-26-000042 · form4.xml · nonDerivative · entry 1

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 466,107

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 26, 2026 Filed Mar 2, 2026 22:44 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
Tax withholdingCommon Shares, No Par Value 22,059 $18.49 $407,870.91
Disclosure

SEC source: 0001860742-26-000041 · form4.xml · nonDerivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 976,524

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:18 UTC
Hashad YehiaEVP of R&D and CMO
GrantCommon Shares, No Par Value 35,046 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000035 · form4.xml · nonDerivative · entry 1

Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 198,906

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:27 UTC
Munsch FrederickSVP, Controller and CAO
GrantCommon Shares, No Par Value 18,253 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000039 · form4.xml · nonDerivative · entry 1

Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 108,484

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:26 UTC
Bonnefoy LucPresident, Surgical
GrantCommon Shares, No Par Value 30,373 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000038 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 117,937

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:24 UTC
Stewart Andrew J.President, GPIC
GrantCommon Shares, No Par Value 32,710 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000037 · form4.xml · nonDerivative · entry 1

Stewart Andrew J. · CIK 0001974516 · President, GPIC

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 95,640

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:13 UTC
Bailey A Robert DEVP & Chief Legal Officer
GrantCommon Shares, No Par Value 52,570 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000033 · form4.xml · nonDerivative · entry 1

Bailey A Robert D · CIK 0001591683 · EVP & Chief Legal Officer

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 223,146

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:04 UTC
Eldessouky SamEVP and CFO
GrantCommon Shares, No Par Value 81,775 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000029 · form4.xml · nonDerivative · entry 1

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 473,169

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 25, 2026 Filed Feb 27, 2026 21:03 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
GrantCommon Shares, No Par Value 327,102 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000028 · form4.xml · nonDerivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 998,583

F1 · shares: Reflects the grant of restricted share units ("RSUs") under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") which are scheduled to vest one-third on each of the first three anniversaries of the date of grant, subject generally to the reporting person's continued service and the terms of the Plan and the applicable award agreement thereunder. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 23, 2026 Filed Feb 24, 2026 21:23 UTC GrantCommon Shares, No Par Value 4,491 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 2

COLLIS STEVEN H · CIK 0001191508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 24,746

F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

Read SEC document
February 23, 2026 Filed Feb 24, 2026 21:23 UTC PurchaseCommon Shares, No Par Value 15,000 $17.81 $267,150.00
Disclosure

SEC source: 0001860742-26-000022 · form4.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,255

F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.77 to $17.85 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
February 23, 2026 Filed Feb 25, 2026 21:58 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
Tax withholdingCommon Shares, No Par Value 65,444 $17.99 $1,177,337.56
Disclosure

SEC source: 0001860742-26-000027 · form4.xml · nonDerivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 671,481

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
February 20, 2026 Filed Feb 24, 2026 21:16 UTC GrantCommon Shares, No Par Value 4,400 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 2

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 76,807

F1 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

Read SEC document
February 20, 2026 Filed Feb 24, 2026 21:16 UTC PurchaseCommon Shares, No Par Value 4,400 $17.90 $78,760.00
Disclosure

SEC source: 0001860742-26-000021 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,407

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:20 UTC
Ling KarenDirector
GrantCommon Shares, No Par Value 4,000 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 2

Ling Karen · CIK 0001597450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 45,676

F2 · shares: Represents matching restricted share units ("MRSUs") granted to the reporting person in connection with the open market purchase of common shares reported on Table I above, pursuant to the issuer's matching share program. One-third of the MRSUs will vest on each of the first, second, and third anniversaries following the date of grant, subject to the reporting person's continued service (except in limited circumstances).

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:20 UTC
Ling KarenDirector
PurchaseCommon Shares, No Par Value 4,000 $17.74 $70,968.00
Disclosure

SEC source: 0001860742-26-000020 · form4.xml · nonDerivative · entry 1

Ling Karen · CIK 0001597450 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 41,676

F1 · price: Reflects a weighted average price. These shares were purchased in multiple transactions at prices ranging from $17.71 to $17.75 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth above.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:19 UTC GrantCommon Shares, No Par Value 5,255 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000019 · form4.xml · nonDerivative · entry 1

COLLIS STEVEN H · CIK 0001191508 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,255

F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:17 UTC GrantCommon Shares, No Par Value 5,255 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000018 · form4.xml · nonDerivative · entry 1

Alfonso Eduardo · CIK 0002104484 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,255

F1 · shares: Reflects the annual grant of restricted share units ("RSUs") to non-employee directors under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated. Vested RSUs are settled in common shares, no par value, of Bausch + Lomb Corporation. The RSUs are scheduled to vest immediately prior to the next annual meeting of shareholders.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:11 UTC GrantCommon Shares, No Par Value 1,451 $17.65 $25,610.15
Disclosure

SEC source: 0001860742-26-000017 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 68,007

F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 19, 2026 Filed Feb 23, 2026 21:09 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 1,239 $17.65 $21,868.35
Disclosure

SEC source: 0001860742-26-000016 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 72,606

F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:39 UTC
Hashad YehiaEVP of R&D and CMO
GrantCommon Shares, No Par Value 29,406 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000011 · form4.xml · nonDerivative · entry 1

Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 163,860

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:44 UTC
Munsch FrederickSVP, Controller and CAO
GrantCommon Shares, No Par Value 12,498 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000015 · form4.xml · nonDerivative · entry 1

Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 90,231

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:42 UTC
Bonnefoy LucPresident, Surgical
GrantCommon Shares, No Par Value 10,202 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000013 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 87,564

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
February 18, 2026 Filed Feb 20, 2026 21:34 UTC
Eldessouky SamEVP and CFO
GrantCommon Shares, No Par Value 70,578 $0.00 $0.00
Disclosure

SEC source: 0001860742-26-000009 · form4.xml · nonDerivative · entry 1

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 391,394

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions as of February 18, 2026. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
November 14, 2025 Filed Nov 18, 2025 21:42 UTC GrantCommon Shares, No Par Value 1,642 $15.60 $25,615.20
Disclosure

SEC source: 0001860742-25-000032 · form4.xml · nonDerivative · entry 1

ROBERTSON RUSSEL C · CIK 0001677301 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 66,556

F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.

Read SEC document
November 14, 2025 Filed Nov 18, 2025 21:23 UTC
Paulson JohnDirector
GrantCommon Shares, No Par Value 1,402 $15.60 $21,871.20
Disclosure

SEC source: 0001860742-25-000027 · form4.xml · nonDerivative · entry 1

Paulson John · CIK 0001394923 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,367

F1 · shares: Reflects restricted share units, each representing a contingent right to receive one common share, no par value, of Bausch + Lomb Corporation.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:40 UTC
Hashad YehiaEVP of R&D and CMO
GrantCommon Shares, No Par Value 17,715 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020239 · form4.xml · nonDerivative · entry 1

Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 134,454

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:48 UTC
Munsch FrederickSVP, Controller and CAO
GrantCommon Shares, No Par Value 7,529 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020243 · form4.xml · nonDerivative · entry 1

Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,733

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:46 UTC
Eldessouky SamEVP and CFO
GrantCommon Shares, No Par Value 42,517 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020242 · form4.xml · nonDerivative · entry 1

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 320,816

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:42 UTC
Bonnefoy LucPresident, Surgical
GrantCommon Shares, No Par Value 6,146 $0.00 $0.00
Disclosure

SEC source: 0001127602-25-020240 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 77,362

F1 · shares: Represents common shares, no par value, of Bausch + Lomb Corporation underlying an award of performance stock units ("PSUs") originally granted to the reporting person on March 1, 2023 under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan, as amended and restated, that satisfied the applicable performance conditions at the target performance level (100%) as of August 5, 2025. The earned PSUs will vest on March 1, 2026, subject generally to the reporting person's continued employment through such date.

Read SEC document
August 05, 2025 Filed Aug 7, 2025 20:23 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
Tax withholdingCommon Shares, No Par Value 4,231 $14.44 $61,095.64
Disclosure

SEC source: 0001127602-25-020237 · form4.xml · nonDerivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 736,925

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 22:34 UTC
Hashad YehiaEVP of R&D and CMO
Tax withholdingCommon Shares, No Par Value 2,841 $14.32 $40,683.12
Disclosure

SEC source: 0001127602-25-019687 · form4.xml · nonDerivative · entry 1

Hashad Yehia · CIK 0001877701 · EVP of R&D and CMO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 116,739

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 22:12 UTC
Munsch FrederickSVP, Controller and CAO
Tax withholdingCommon Shares, No Par Value 1,090 $14.32 $15,608.80
Disclosure

SEC source: 0001127602-25-019665 · form4.xml · nonDerivative · entry 1

Munsch Frederick · CIK 0001864367 · SVP, Controller and CAO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,204

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 22:19 UTC
Bonnefoy LucPresident, Surgical
Tax withholdingCommon Shares, No Par Value 2,167 $14.32 $31,031.44
Disclosure

SEC source: 0001127602-25-019670 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,216

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
July 25, 2025 Filed Jul 28, 2025 21:53 UTC
Eldessouky SamEVP and CFO
Tax withholdingCommon Shares, No Par Value 3,996 $14.32 $57,222.72
Disclosure

SEC source: 0001127602-25-019662 · form4.xml · nonDerivative · entry 1

Eldessouky Sam · CIK 0001558676 · EVP and CFO

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 278,299

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document
July 21, 2025 Filed Jul 23, 2025 21:35 UTC
SAUNDERS BRENT LDirector · CEO and Chairman of the Board
GrantPerformance Stock Units · Derivative 150,000 $0.00 $0.00
Disclosure

SEC source: 0000950170-25-097980 · ownership.xml · derivative · entry 1

SAUNDERS BRENT L · CIK 0001268854 · Director · CEO and Chairman of the Board

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 900,000

Underlying: Common Shares, No Par Value · 900,000 shares

Expires not disclosed

F1 · derivative.exercise_price: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan.

F2 · derivative.exercise_price: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date.

F3 · derivative.exercise_price: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment.

F1 · derivative.exercise_date: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan.

F2 · derivative.exercise_date: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date.

F3 · derivative.exercise_date: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment.

F1 · derivative.expiration_date: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan.

F2 · derivative.expiration_date: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date.

F3 · derivative.expiration_date: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment.

F1 · derivative.underlying_shares: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan.

F2 · derivative.underlying_shares: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date.

F3 · derivative.underlying_shares: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment.

F1 · balance_after: Reflects an amendment on July 21, 2025 (the "Amendment") to an award of performance stock units ("PSUs") originally granted to the reporting person under the Bausch + Lomb Corporation 2022 Omnibus Incentive Plan (as amended and restated, the "Plan") on February 23, 2023 (the "New Hire PSUs"). Each PSU reflects the right to receive one common share, no par value, of the Issuer, subject to the terms of the Plan.

F2 · balance_after: Pursuant to the Amendment, the New Hire PSUs may be earned and vest between 120% and 330% of the target award on February 23, 2029 (the "Measurement End Date") based on the level of achievement of (i) specified share-price hurdle goals and (ii) a cumulative Adjusted EBITDA performance modifier goal, subject generally to the reporting person's continued employment through the Measurement End Date.

F3 · balance_after: The reporting person previously reported beneficial ownership of the target number of common shares underlying the New Hire PSUs (750,000 common shares) in the reporting person's Form 3 filed on March 6, 2023. As a result of the Amendment, the reporting person is now reporting the acquisition of beneficial ownership of an additional 150,000 PSUs pursuant to the New Hire PSU, which collectively reflects beneficial ownership of the minimum number of shares that are eligible to vest on the Measurement End Date (900,000 common shares) as a result of the Amendment.

Read SEC document
June 13, 2025 Filed Jun 16, 2025 20:46 UTC
Bonnefoy LucPresident, Surgical
Tax withholdingCommon Shares, No Par Value 968 $12.33 $11,935.44
Disclosure

SEC source: 0001127602-25-017578 · form4.xml · nonDerivative · entry 1

Bonnefoy Luc · CIK 0001980767 · President, Surgical

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 73,383

F1 · shares: This number represents common shares withheld to satisfy the tax withholding obligations due upon vesting of restricted share units.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.